Sanofi (EPA:SAN)
France
· Delayed Price · Currency is EUR 92.92
+1.16 (1.26%)
May 9, 2025, 5:38 PM CET
Sanofi Revenue
Sanofi had revenue of 10.61B EUR in the quarter ending March 31, 2025, a decrease of -4.61%. This brings the company's revenue in the last twelve months to 45.17B, down -2.42% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.17B
Revenue Growth
-2.42%
P/S Ratio
2.51
Revenue / Employee
544.97K
Employees
82,878
Market Cap
113.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |
| Clariane SE | 5.28B |
Sanofi News
- 1 day ago - COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why - Benzinga
- 3 days ago - Sanofi: Investing in prevention builds Europe's health and competitiveness - GlobeNewsWire
- 4 days ago - Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday? - Benzinga
- 5 days ago - Notable healthcare headlines for the week: Gilead, CVS Health, Sanofi in focus - Seeking Alpha
- 9 days ago - Press Release: Annual General Meeting of April 30, 2025 - GlobeNewsWire
- 9 days ago - Sanofi becomes a pure play pharma after 50% stake sale in Opella - Seeking Alpha
- 9 days ago - Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader - GlobeNewsWire
- 10 days ago - Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race - GlobeNewsWire